Table 1.
Oral organisms associated with distant tumors.
| Cancer | Organisms | Sample type | Reference |
|---|---|---|---|
| Esophageal cancer | Increase of T. forsythia and P. gingivalis | Oral rinse | (64) |
| Esophageal cancer | Streptococcus anginosus, S. mitis, Treponema denticola | Saliva | (65) |
| Esophageal cancer | 3 taxon model: Lautropia, Streptococcus, and an unspecified genus of the order Bacteroidales. (AUC = 0.94) | Oral swab | (66) |
| Esophageal cancer | Overall decreased microbial diversity in cancer patients | Saliva | (67) |
| Pancreatic cancer | Porphyromonas gingivalis, Aggregatibacteractinomycetemcomitans | Oral rinse | (68) |
| Pancreatic cancer | Porphyromonas gingivalis | Blood (antibodies) | (69) |
| Pancreatic cancer | Fusobacterium spp. | Tissue from pancreatic ductal adenocarcinoma | (70) |
| Pancreatic cancer | 2 taxon model: Streptococcus mitis and Neisseria elongata. (AUC =0.90) | Saliva | (71) |
| Pancreatic cancer | Significative higher ratio of Leptotrichiato Porphyromonas was found in cancer patients. | Saliva | (72) |
| Pancreatic cancer | Association with β-diversity and Haemophilus | Saliva | (73) |
| Pancreatic cancer | Fusobacterium spp. | Tissue samples, swabs, stool | (74) |
| Pancreatic cancer | Streptococcus thermophilus higher in cancer, and Haemophilus parainfluenzae and Neisseria flavescens lower in cancer | Saliva | (75) |
| Pancreatic cancer | Haemophilus, Porphyromonas, Leptotrichia and Fusobacterium could distinguish cancer patients from healthy subjects | Tongue coating microbiota | (76) |
| Hepatic cancer | Fusobacterium and Oribacterium. Increase in diversity. | Tongue coat | (77) |
| Lung cancer | Capnocytophaga sp., Veillonella sp. | Saliva | (78) |
| Lung cancer | Streptococcus and Veillonella | Airway brushings | (79) |
| Lung cancer | Sphingomonas and Blastomonas | Saliva | (80) |
| Lung cancer | Streptococcus and Veillonella | Saliva | (81) |
| Colorectal cancer | T. denticola and Prevotella sp. oral taxon 313 | Oral rinse | (82) |
| Colorectal cancer | Fusobacterium sp., Porphyromonas sp. | Stool | (83) |
| Colorectal cancer | Fusobacterium sp. | Colorectal cancer tissues | (84) |
| Colorectal cancer | Lactobacillus and Rothia | Oral rinse | (85) |
| Colorectal cancer | Streptococcus and Prevotella spp. | Oral swabcolonic mucosae and stools, colorectal polyps or controls | (86) |
| Colorectal cancer | Fusobacterium sp. | Tissue and stool samples | (87) |
| Colorectal cancer | Fusobacterium nucleatum | Colorectal tissue biopsies | (88) |
| Colorectal cancer | Fusobacterium sp. | Colorectal tissue biopsies | (89) |
| Colorectal cancer | Fusobacterium sp. | Colorectal tissue biopsies | (21) |
| Colorectal cancer | Fusobacterium sp., Lactococcus sp. | Colorectal tissue biopsies | (90) |
| Digestive tract cancer | Actinomyces odontolyticus, Steptococcus parasinguinis, Corynebacterium spp., Neisseria spp.,TM7[G-1] sp., Porphyromonas gingivalis, Fusobacterium nucleatum, Neisseria elongata and Streptococcus sanguinis | Saliva | (91) |
| Colorectal cancer | Fusobacterium nucleatum, Parvimonas micra, and Peptostreptococcus stomatis | Colon tissue | (92) |
| Colorectal cancer | Peptostreptococcus stomatis, Fusobacteriumnucleatum, Parvimonas spp. | Meta-analysisfecal samples | (93) |
| Gastric cancer | Overall diversity of tongue coating microbiota was reduced | Tongue coating | (94) |
| Gastric cancer | Overall increased microbial diversity in cancer patients | Saliva and plaque samples | (95) |
| Gastric cancer | 6 bacterial clusters were identified to distinguish cancer patients from controls. (cluster 6 had AUC = 0.76) | Tongue coating | (96) |
| Breast cancer | Corynebacterium, Staphylococcus, Actinomyces, and Propionibacteriaceae | Urine | (97) |
| Breast cancer | Fusobacterium, Atopobium, Gluconacetobacter, Hydrogenophaga and Lactobacillus | Breast tissue | (98) |
| Breast cancer | Coriobacteriaceae | Oral rinse | (99) |